The Oncology Institute (TOI)
(Delayed Data from NSDQ)
$0.29 USD
0.00 (1.19%)
Updated Sep 11, 2024 03:59 PM ET
After-Market: $0.29 0.00 (0.55%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.06 |
EPS Last Quarter | -0.17 |
Last EPS Surprise | -70.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.42 |
Next Year | -0.16 |
EPS (TTM) | -0.79 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 107.54M | 109.15M | NA | 482.76M |
# of Estimates | 1 | 1 | NA | 1 |
High Estimate | 107.54M | 109.15M | NA | 482.76M |
Low Estimate | 107.54M | 109.15M | NA | 482.76M |
Year ago Sales | 82.04M | 85.79M | 324.24M | NA |
Year over Year Growth Est. | 31.08% | 27.23% | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.06 | -0.07 | -0.42 | -0.16 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.06 | -0.07 | -0.42 | -0.16 |
Low Estimate | -0.06 | -0.07 | -0.42 | -0.16 |
Year ago EPS | -0.19 | -0.21 | -0.69 | -0.42 |
Year over Year Growth Est. | 68.42% | 66.67% | 39.13% | 61.90% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.06 | -0.07 | -0.42 | -0.16 |
7 Days Ago | -0.06 | -0.07 | -0.42 | -0.16 |
30 Days Ago | -0.06 | -0.07 | -0.42 | -0.16 |
60 Days Ago | -0.06 | -0.07 | -0.42 | -0.16 |
90 Days Ago | -0.06 | -0.07 | -0.42 | -0.16 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.06 | -0.07 | -0.42 | -0.16 |
Zacks Consensus Estimate | -0.06 | -0.07 | -0.42 | -0.16 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.17 | -0.22 | -0.21 | -0.19 | NA |
Estimate | -0.10 | -0.12 | -0.11 | -0.13 | NA |
Difference | -0.07 | -0.10 | -0.10 | -0.06 | -0.08 |
Surprise | -70.00% | -83.33% | -90.91% | -46.15% | -72.60% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more